Source: centralcharts

Press Release: Novelion Therapeutics : Novelion Therapeutics Ceases to be a Reporting Issuer in Canada

VANCOUVER, British Columbia, July 08, 2020 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. ("Novelion" or the "Company") by Alvarez & Marsal Canada Inc.,...

Read full article »
Novelion Therapeutics's Competitors | Novelion Therapeutics's News | Novelion Therapeutics's Financials
Stay up-to-date with the latest news on Novelion Therapeutics
Est. Annual Revenue
$100-500M
Est. Employees
100-250
Benjamin Harshbarger's photo - Interim-CEO of Novelion Therapeutics

Interim-CEO

Benjamin Harshbarger

CEO Approval Rating

83/100

Read more
Stay up-to-date with the latest news on Novelion Therapeutics